Before the advent of OCT, FA was the standard tool used to diagnosis macular edema. The finding of a ''petaloid'' pattern of late leakage is classic for the diagnosis of cystoid macular edema.

METHODS: A total of 10 eyes of 10 patients (six males and four females) with macular edema due to CRVO were studied before and after intravitreal use of bevacizumab with MFERG and OCT. The post ...

One of the critical applications of OCT is the segmentation of retinal fluids, which can indicate conditions such as diabetic macular edema and age-related macular degeneration. Recent research ...

Examining the performance of AI algorithms versus human graders in neovascular age-related macular degeneration ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Initially, macular telangiectasia (MacTel ... Clinicians may misinterpret the black spaces identified on OCT as edema, which can contribute to misdiagnosis. If patients with MacTel type 2 are ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema (DME), which is the ...

Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ...